Semaglutide provides multifaceted kidney protection and improves structural markers in patients with T2D and chronic kidney disease.

Dual-hormone fully closed-loop therapy increases time in glycemic range compared with multiple daily insulin injections (MDI), but not compared with hybrid closed-loop (HCL) therapy in adults with ...

Elevated menopause proteomic scores are associated with poorer cognitive outcomes and increased risk for Alzheimer disease ...

GLP-1 RAs and SGLT-2 inhibitors reduce risk for renal deterioration in patients with type 2 diabetes (T2D) and albuminuria.

Sustained smoking cessation for at least 8 years significantly reduces risk for microvascular complications in patients with type 2 diabetes.

Postoperative benefits include lower odds of major adverse cardiovascular events or infections. HealthDay News — Perioperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated ...

Insulin resistance may partially explain the increased long-term cardiovascular risk. HealthDay News — Premature menopause is associated with higher insulin levels and a greater risk for ...

Improvement were seen in the lumbar spine vs estrogen therapy alone in postmenopausal women. HealthDay News — The combination of estrogen and testosterone therapy (E+T) may improve bone mineral ...

Retatrutide therapy significantly decreases body weight and improves knee osteoarthritis pain and events in OSA in adults ...

High-dose oral menopausal hormone therapy increases risk for venous thromboembolism, ischemic stroke, and myocardial infarction.

Off-label testosterone prescriptions for women have surged; most are not for the approved indication of hypoactive sexual desire disorder.